MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2

Cancer Biology and Therapy

Volumn 16, Issue 1, 2015, Pages 160-169

  Zhou, Xiaoying ^a,b   Xia, Yang ^a,b   Li, Lin ^a,b   Zhang, Guoxin ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

cell growth; cell cycle regulators; gastric cancer; Helicobacter pylori; miR 101; SOCS2; tumorigenesis

Indexed keywords

BETA ACTIN; CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E1; CYCLIN E2; MESSENGER RNA; MICRORNA 101; MICRORNA 26A; PROTEIN P14; PROTEIN P16; PROTEIN P21; PROTEIN P27; SUPPRESSOR OF CYTOKINE SIGNALING 2; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MICRORNA; MIRN101 MICRORNA, HUMAN; SOCS2 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ECTOPIC EXPRESSION; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MKN45 CELL LINE; NONHUMAN; ONCOGENE C MYC; PERCENTAGE OF CELLS IN G1 PHASE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH CARCINOGENESIS; WESTERN BLOTTING; ANIMAL; BINDING SITE; CELL CYCLE; CELL TRANSFORMATION; CHEMISTRY; COMPLICATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HELICOBACTER INFECTION; NUCLEOTIDE SEQUENCE; PATHOLOGY; RNA INTERFERENCE; STOMACH NEOPLASMS; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL CYCLE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HETEROGRAFTS; HUMANS; MICRORNAS; RNA INTERFERENCE; STOMACH NEOPLASMS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TUMOR BURDEN;

EID: 84944311817     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/15384047.2014.987523     Document Type: Article

References (19)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63(1):11-30; PMID:23335087; http://dx.doi.org/10.3322/caac.21166
2. Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol 2014; 20(18):5191-5204
3. Lordick F, Allum W, Carneiro F, Mitry E, Tabernero J, Tan P, Van Cutsem E, van de Velde C, Cervantes A. Unmet needs and challenges in gastric cancer: The way forward. Cancer Treat Rev 2014; 40(6):692-700; PMID:24656602; http://dx.doi.org/10.1016/j.ctrv.2014.03.002
4. Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell 2012; 148(6):1172-87; PMID:22424228; http://dx.doi.org/10.1016/j.cell.2012.02.005
5. Motoyama K, Inoue H, Nakamura Y, Uetake H, Sugihara K, Mori M. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res 2008; 14(8):2334-40; PMID:18413822; http://dx.doi.org/10.1158/1078-0432.CCR-07-4667
6. Zhou X, Xia Y, Su J, Zhang G. Down-regulation of miR-141 induced by helicobacter pylori promotes the invasion of gastric cancer by targeting STAT4. Cell Physiol Biochem 2014; 33(4):1003-12; PMID:24732377; http://dx.doi.org/10.1159/000358671
7. Matsushima K, Isomoto H, Inoue N, Nakayama T, Hayashi T, Nakayama M, Nakao K, Hirayama T, Kohno S. MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer 2011; 128(2):361-70; PMID:20333682; http://dx.doi.org/10.1002/ijc.25348
8. Huang ZB, Zhou X, Xu J, Du YP, Zhu W, Wang J, Shu YQ, Liu P. Prognostic value of preoperative serum tumor markers in gastric cancer. World J Clin Oncol 2014; 5(2):170-6; PMID:24829865; http://dx.doi.org/10.5306/wjco.v5.i2.170
9. González CA, Sala N, Rokkas T. Gastric cancer: epidemiologic aspects. Helicobacter 2013; 18 Suppl 1:34-8; PMID:24011243; http://dx.doi.org/10.1111/hel.12082
10. Song JH, Meltzer SJ. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology 2012; 143(1):35-47; PMID:22580099; http://dx.doi.org/10.1053/j.gastro.2012.05.003
11. Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT, Xia YJ, Ye ZY, Tao HQ. MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 2010; 46(12):2295-303; PMID:20712078; http://dx.doi.org/10.1016/j.ejca.2010.05.012
12. Wang R, Wang HB, Hao CJ, Cui Y, Han XC, Hu Y, Li FF, Xia HF, Ma X. MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1. PLoS One 2012; 7(10):e46173; PMID:23071542; http://dx.doi.org/10.1371/journal.pone.0046173
13. Guo F, Cogdell D, Hu L, Yang D, Sood AK, Xue F, Zhang W. MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma. Oncol Rep 2014; 31(5):2021-8; PMID:24677166
14. Yin J, Wang M, Jin C, Qi Q. miR-101 sensitizes A549 NSCLC cell line to CDDP by activating caspase 3-dependent apoptosis. Oncol Lett 2014; 7(2):461-465; PMID:24396470
15. Rico-Bautista E, Flores-Morales A, Fernández-Pérez L. Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions. Cytokine Growth Factor Rev 2006; 17(6):431-9; PMID:17070092; http://dx.doi.org/10.1016/j.cytogfr.2006.09.008
16. Hoefer J, Kern J, Ofer P, Eder IE, Schäfer G, Dietrich D, Kristiansen G, Geley S, Rainer J, Gunsilius E, Klocker H, Culig Z, Puhr M. SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer. Endocr Relat Cancer 2014; 21(2):175-87; PMID:24280133; http://dx.doi.org/10.1530/ERC-13-0446
17. Nagpal N, Ahmad HM, Molparia B, Kulshreshtha R. MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer. Carcinogenesis 2013; 34(8):1889-99; PMID:23542418; http://dx.doi.org/10.1093/carcin/bgt107
18. Cha B, Kim KH, Matsui H, Kim H. Expression of suppressors of cytokine signaling-3 in Helicobacter pylori-infected rat gastric mucosal RGM-1cells. Ann NY Acad Sci 2007; 1096:24-8; PMID:17405912; http://dx.doi.org/10.1196/annals.1397.066
19. Yousef M, Trinh HV, Allmer J. Intersection of MicroRNA and gene regulatory networks and their implication in cancer. Curr Pharm Biotechnol 2014; 15:445-54; PMID:24846065